Health&Beauty- Page 105

The FINANCIAL -- As part of a nationwide effort to help communities fight congestion, Pfizer Consumer Healthcare, the makers of Advil Congestion Relief, stopped in St. Louis to help Kingdom House, a local social service provider, create space to help community needs.

The FINANCIAL -- The board of directors of Pfizer Inc. today declared a 22-cent second-quarter 2012 dividend on the company’s common stock, payable June 5, 2012, to shareholders of record at the close of business on May 11, 2012.

The FINANCIAL -- Novartis announced that the US Food and Drug Administration approved Afinitor tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.

The FINANCIAL -- Novartis associates across 54 countries are engaging in volunteer activities to benefit people in their local communities in celebration of the company's annual Community Partnership Day (CPD).

The FINANCIAL -- The first three Novartis QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease all met their primary endpoints.

The FINANCIAL -- The Bayer Climate Program has passed a significant milestone: One year earlier than planned, the company has achieved a more than 20 percent increase in energy efficiency in its data centers compared with 2009.

The FINANCIAL -- Arena Pharmaceuticals announced the filing of a Marketing Authorization Application with the European Medicines Agency for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese or

The FINANCIAL -- Polyurethane materials for lightweight yet rigid designs are the focal point of Bayer MaterialScience’s exhibit at Stand P 14 at the JEC composites fair from March 27 - 29 in Paris, France.